MX354598B - Uso de neuregulina para tratar lesion de nervio periferico. - Google Patents

Uso de neuregulina para tratar lesion de nervio periferico.

Info

Publication number
MX354598B
MX354598B MX2014011838A MX2014011838A MX354598B MX 354598 B MX354598 B MX 354598B MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 354598 B MX354598 B MX 354598B
Authority
MX
Mexico
Prior art keywords
peripheral nerve
nerve injury
neuregulin
treat peripheral
treat
Prior art date
Application number
MX2014011838A
Other languages
English (en)
Spanish (es)
Other versions
MX2014011838A (es
Inventor
Anthony O Caggiano
Anindita Ganguly
Jennifer Iaci
Anthony J Bella
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of MX2014011838A publication Critical patent/MX2014011838A/es
Publication of MX354598B publication Critical patent/MX354598B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2014011838A 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico. MX354598B (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury

Publications (2)

Publication Number Publication Date
MX2014011838A MX2014011838A (es) 2015-03-09
MX354598B true MX354598B (es) 2018-03-12

Family

ID=48128617

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011838A MX354598B (es) 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico.

Country Status (15)

Country Link
US (3) US20150094263A1 (enExample)
EP (3) EP2830645B1 (enExample)
JP (4) JP6420233B2 (enExample)
CN (2) CN104321072A (enExample)
AU (4) AU2013237896B2 (enExample)
BR (1) BR112014024308B1 (enExample)
CA (1) CA2869070A1 (enExample)
DK (2) DK3278811T3 (enExample)
ES (2) ES2647917T3 (enExample)
IL (3) IL288785B2 (enExample)
MX (1) MX354598B (enExample)
NZ (1) NZ700546A (enExample)
PL (2) PL3278811T3 (enExample)
PT (2) PT2830645T (enExample)
WO (1) WO2013149163A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3338791T3 (da) 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
PL3235504T3 (pl) 2009-10-14 2020-03-31 Acorda Therapeutics, Inc. Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL294038A (en) * 2015-12-04 2022-08-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
CA3082878C (en) 2017-11-17 2024-02-20 The Research Foundation for State University of New York A method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
CN114929099B (zh) * 2019-08-01 2025-08-15 马克·埃文斯 用于在分娩期间和分娩之前降低人类胎儿神经损伤风险及鉴定神经损伤存在的方法和设备
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
EP1028735A4 (en) * 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
CA2409996C (en) * 2000-05-23 2016-03-01 Cenes Pharmaceuticals, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2009046453A2 (en) * 2007-10-05 2009-04-09 New England Medical Center (Nemc) Use of neuregulin-1 in reducing brain damage
CN104645315A (zh) * 2008-02-29 2015-05-27 阿索尔达治疗公司 达到所需胶质生长因子2血浆水平的方法
DK3338791T3 (da) * 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
KR101237927B1 (ko) * 2009-05-07 2013-03-04 (주)문엔제이 신경손상 및 신경질환 예방 또는 치료용 약학조성물
PL3235504T3 (pl) * 2009-10-14 2020-03-31 Acorda Therapeutics, Inc. Zastosowanie neureguliny do leczenia uszkodzenia nerwu obwodowego
CA2845198A1 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
JP7108724B2 (ja) 2022-07-28
PT3278811T (pt) 2021-03-03
EP3278811B1 (en) 2020-12-02
EP3842059A1 (en) 2021-06-30
EP2830645B1 (en) 2017-08-30
IL234882B (en) 2020-03-31
ES2647917T3 (es) 2017-12-27
HK1249038A1 (en) 2018-10-26
CN104321072A (zh) 2015-01-28
JP2021059605A (ja) 2021-04-15
DK3278811T3 (da) 2021-03-01
IL273186B (en) 2022-01-01
AU2018200592A1 (en) 2018-02-15
JP6420233B2 (ja) 2018-11-07
CA2869070A1 (en) 2013-10-03
HK1206632A1 (en) 2016-01-15
PL3278811T3 (pl) 2021-08-02
US20230117985A1 (en) 2023-04-20
IL273186A (en) 2020-04-30
PL2830645T3 (pl) 2018-01-31
BR112014024308A2 (pt) 2017-08-08
IL288785A (en) 2022-02-01
IL234882A0 (en) 2014-12-31
AU2013237896A1 (en) 2014-10-16
AU2019202401A1 (en) 2019-05-02
EP2830645A1 (en) 2015-02-04
JP2019131582A (ja) 2019-08-08
EP3278811A1 (en) 2018-02-07
JP2015514096A (ja) 2015-05-18
AU2019202401B2 (en) 2020-10-15
AU2013237896B2 (en) 2017-11-02
BR112014024308B1 (pt) 2021-11-30
DK2830645T3 (da) 2017-11-20
CN106511971A (zh) 2017-03-22
BR112014024308A8 (pt) 2018-01-23
US20160346353A1 (en) 2016-12-01
PT2830645T (pt) 2017-11-28
AU2020260539A1 (en) 2020-11-26
MX2014011838A (es) 2015-03-09
WO2013149163A1 (en) 2013-10-03
ES2857810T3 (es) 2021-09-29
US20150094263A1 (en) 2015-04-02
NZ700546A (en) 2017-05-26
JP2017149746A (ja) 2017-08-31
IL288785B (en) 2022-11-01
IL288785B2 (en) 2023-03-01

Similar Documents

Publication Publication Date Title
MX2014011838A (es) Uso de neuregulina para tratar lesion de nervio periferico.
IN2015DN00438A (enExample)
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
PH12015500525A1 (en) Formulations of enzalutamide
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
PH12013502623A1 (en) Metalloenzyme inhibitor compounds
IN2014DN06792A (enExample)
PH12015501983B1 (en) Peptides and compositions for treatment of joint damage
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
MX2013007603A (es) Antagonistas de hedgehog que tienen residuos que se unen al zinc.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2015000804A (es) Composiciones y metodos para tratar el sarcoma de ewing y otros trastornos relacionados con ews-fli1.
MX362111B (es) Un metodo para mejorar la funcion hepatica.
WO2012170664A3 (en) Methods of cancer treatment and prevention through the modulation of sirt4 activity
NZ750581A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
PH12016500824A1 (en) Compositions and methods for the treatment of viral diseases with pde4 modulators

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration